A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User Mosheideh, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User cherokee_1_feather, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User shortrockoon, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User SexandTrees, in the TheFightThatMatters subreddit, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User coconutcorbasi, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User dannylenwinn, in the World subreddit, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User Tsumagadeio, in the CoronavirusUS subreddit, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can ... [r/science by u/mvea] User topredditbot, in the All the top reddit posts subreddit, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User worldnewsbot, in the News From Around The World subreddit, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User officialpanduh, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User BlondFaith, in the Oxford Covid Vaccine subreddit, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User MarshallBrain, in the MarshallBrain - A place for people who love learning how everything works subreddit, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User cseamunchkin, in the cseamunchkin subreddit, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User cseamunchkin, in the covid19Oklahoma subreddit, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User alloutz, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User doppl, in the Good Rising Posts subreddit, 21 Jul 2020
A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. User mvea, in the Reddit Science subreddit, 20 Jul 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised [non-placebo] controlled trial User Monky11, in the Novel Coronavirus (COVID-19) subreddit, 20 Jul 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (Oxford Vaccine is safe and works well against COVID-19) User InquisitorCOC, in the InquisitorCOC subreddit, 20 Jul 2020